Domov › Velika depresivna motnja › New York › New York City
Klinične študije za Velika depresivna motnja v New York City, NY
36 študij za Velika depresivna motnja išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Vključevanje udeležencevFaza 3
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Vključevanje udeležencevFaza 3
- Adams Clinical Harlem, New York
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Vključevanje udeležencevFaza 3
- Fieve Clinical Research Inc, New York
- Adams Clinical Harlem, New York
- Manhattan Behavioral Medicine, New York
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Vključevanje udeležencevFaza 3
- Manhattan Behavioral Medicine, New York
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Vključevanje udeležencevFaza 3
- Fieve Clinical Research Inc, New York
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Vključevanje udeležencevFaza 2
- Ima Clinical Research - Nyc Midtown, New York
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Vključevanje udeležencevFaza 3
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
DBS for TRD With the Medtronic Percept PC
Vključevanje udeležencev
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Pattern Separation in Major Depressive Disorder
Vključevanje udeležencevFaza 1
- New York State Psychiatric Institute (NYSPI), New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Vključevanje udeležencevFaza 2
- Seaport Investigator Site, New York
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Vključevanje udeležencevFaza 3
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Vključevanje udeležencevFaza 2
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Vključevanje udeležencev
- Mount Sinai Hospital, New York
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Vključevanje udeležencevFaza 2
- Draig Clinical Site, New York
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Vključevanje udeležencevFaza 3
- Neurocrine Clinical Site, New York
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Vključevanje udeležencevFaza 3
- Neurocrine Clinical Site, New York
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Vključevanje udeležencevFaza 2
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Vključevanje udeležencevFaza 3
- Clinical Research Site, New York
- Clinical Research Site, New York
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Vključevanje udeležencevFaza 3
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
Vključevanje udeležencev
- NYU Langone Health, New York
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Vključevanje udeležencevFaza 2
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
tDCS: Sleep to Mood in Depression (S2M-D)
Vključevanje udeležencev
- NYU Langone Health, New York
Triage Survey for Psychiatry Research Eligibility
Vključevanje udeležencevOpazovalna študija
- Adams Clinical, Harlem, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Vključevanje udeležencevFaza 2
- The Medical Research Network, LLC, New York
Aβ Dynamics in LLMD
Vključevanje udeležencevFaza 4
- NYU Langone Health, New York
Maintenance rTMS for Depression (Maitr-De)
Vključevanje udeležencev
- Weill Cornell Medicine, New York
Neutralizing Interleukin (IL)-6
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- Icahn School of Medicine at Mount Sinai, New York
Mindfulness-Based fMRI Neurofeedback for Depression
Vključevanje udeležencev
- Columbia University Irving Medical Center, New York
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
Vključevanje udeležencev
- Weill Cornell Medicine, New York
Biomarker-guided rTMS for Treatment Resistant Depression
Vključevanje udeležencevFaza 3
- Weill Cornell Medicine, New York
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
Vključevanje udeležencev
- NYU Langone Health, New York
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
Vključevanje udeležencev
- Icahn School of Medicine at Mount Sinai, New York
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Vključevanje udeležencevFaza 2
- Icahn School of Medicine at Mount Sinai, New York
Neural Circuit Effects of Ketamine in Depression
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
- Icahn School of Medicine at Mount Sinai, New York
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Vključevanje udeležencevFaza 2
- Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Vključevanje udeležencevFaza 4
- Clinical Research Site, New York
Študije za Velika depresivna motnja v drugih mestih
- Boston, MA31 študij
- Atlanta, GA25 študij
- Philadelphia, PA23 študij
- Orlando, FL19 študij
- Miami, FL18 študij
- Chicago, IL17 študij
- Tampa, FL17 študij
- San Diego, CA16 študij
- Houston, TX16 študij
- Little Rock, AR14 študij
- Austin, TX13 študij
- Las Vegas, NV13 študij
Druge študije v New York City
- Rak dojke136 študij
- Nemalicelični pljučni rak121 študij
- Rak (vse vrste)109 študij
- Rak prostate103 študij
- Metastatski rak93 študij
- Kolorektalni rak78 študij
- Rak jajčnikov69 študij
- Rak pljuč60 študij
- Množni mielom60 študij
- Rak trebušne slinavke60 študij
- Rak endometrija52 študij
- Akutna mieločna levkemija51 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.